Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Bausch and Lomb UK Ltd., Bausch & Lomb House, 106 London Road, Kingston-Upon-Thames, Surrey, KT2 6TN, UK
Vizidor 20 mg/ml eye drops solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution. Clear, colourless, slightly viscous, aqueous solution with a pH between 5.0 and 6.0 and an osmolality of 270-310 mOsM/Kg. |
Each ml contains 20 mg of dorzolamide (as dorzolamide hydrochloride).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dorzolamide |
Dorzolamide is a potent inhibitor of human carbonic anhydrase II. Following topical ocular administration, dorzolamide reduces elevated intra-ocular pressure, whether or not associated with glaucoma. |
| List of Excipients |
|---|
|
Hydroxyethyl cellulose |
5 ml solution in a white opaque 11 ml LDPE bottle and white Novelia nozzle (HDPE and silicone) with a white HDPE cap.
Pack sizes: 1 or 3 bottles in cardbox.
Not all pack sizes may be marketed.
Bausch and Lomb UK Ltd., Bausch & Lomb House, 106 London Road, Kingston-Upon-Thames, Surrey, KT2 6TN, UK
PL 03468/0087
24 June 2016
| Drug | Countries | |
|---|---|---|
| VIZIDOR | Estonia, Croatia, Lithuania, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
